Mr. Speaker, I rise today to speak to Bill C-13, particularly because it affects low income Canadians and fails to address health problems, including chronic cerebrospinal venous insufficiency and rare disorders.
Specifically, Bill C-13 deliberately excludes low income Canadians from programs such as the family caregiver tax credit. If people quit their job to take care of a sick loved one at home, they likely would not qualify for any benefits as the Conservatives have put in place a minimum threshold to qualify. I think it is unconscionable to deliberately exclude the very people who are most in need of help. It important to remember that one of Canadians' most deeply held values is fairness.
How then can Canada be one of the few developed countries without a national student nutrition program? Sadly, one in five Canadian children lives below the poverty line which may lead to poor nutritional status and poor child health outcomes. Canadian children from all income brackets are vulnerable to inadequate nutrition. Many children go to class hungry as 40% of elementary students and 62% of secondary school students do not eat a nutritious breakfast.
Hungry children cannot learn. Their learning capabilities are affected by how recently they have eaten. Malnutrition in early life can limit long-term intellectual development. Moreover, Canadian children and youth experience unprecedented rates of type 2 diabetes and obesity because they do not have the knowledge to make healthy food choices and do not have access to the healthy food they need for health and learning.
The Toronto Foundation for Student Success has more than 600 schools in Toronto, 142,000 children and youth, and 3,000 community volunteers with a total of 20,350,000 meals served annually. Toronto research has found that student nutrition programs reduce absenteeism, suspensions and expulsions by 50%; improve performance on standardized literacy and numeracy tests; dramatically impact credit accumulation in secondary school, which is a key indicator of graduation; create a sense of belonging and improve the morale of schools. Toronto research showed that the health impacts include: increased consumption of fruit, vegetables, whole grain foods, and healthy eating habits which prevents diabetes, high blood pressure and obesity.
Student nutrition programs are needed in aboriginal, remote and rural communities, and the same behavioural learning and health impacts are found in all communities.
Feeding Our Future showed that 78% of grade 10 students, who reported eating morning meals most days, were on track to complete their diploma, meaning they earned 15 or more credits versus 61% who went without food.
The Boston Consulting Group, BCG, has shown that on average each high school graduate contributes an extra $75,000 annually to the economy. If providing food at school increases graduation rates by just 3%, based on the BCG figures, a national school meal program implemented in Canada's high schools at a cost of just $1.25 a day would result in a net payback of more than $500 million annually.
Outside Canada school meals are viewed as an investment rather than a cost. Improving child and youth nutrition, health and social development feeds regional economic development.
For example, in Brazil food is a constitutional right. A massive national program feeds 47 million students at 190,000 schools each day. Access to nutritionally adequate and safe food is a right of every individual. Therefore, I think it is incumbent upon each of us to fight for a national school nutrition program for all of our children.
I would like to address a second item missing from the budget: funding for clinical trials for chronic cerebrospinal venous insufficiency, or CCSVI.
After much resistance, the federal government announced this summer that it would fund clinical trials for CCSVI. This was welcome news for Canadians with MS and for their families. However, this decision took far too long to arrive at, and, since the announcement, no plan has been provided describing how the government plans to establish these trials.
I want to be very clear: right now, all we have is announcements; what we need is action. Canadians with MS cannot afford to wait, as any delay possibly means more damage.
Mr. Speaker, 30%-50% of MS patients who are untreated worsen by one EDSS score in one year, and 50% with relapsing-remitting MS later develop a progressive form of the disease for which there are no drugs. The reality is that one month can mean the difference between walking and not walking, or between living independently and living in care.
CIHR has recommended a phase I/II clinical trial, which is usually undertaken to assess safety. However, angioplasty is an accepted standard of care practice and routinely used for many conditions. The U.S. Food and Drug Administration has accepted the basic safety information for angioplasty, since it has already approved three double-blind phase II clinical trials, which are already being conducted in the United States. There is no need for a phase I trial in Canada. It will waste time and money and would provide nothing beyond what is already known worldwide about this procedure.
What is needed is an adaptive phase II/III trial, which would permit a rapid and seamless transition from the phase II trial--subject, of course, to interim assessments of safety and efficacy--to a full phase III trial. This approach would still address all the regulatory requirements and answer all the key safety and efficacy questions, but it would also save time and cost.
Moreover, we need experts who are actively engaged in diagnosis and treatment of CCSVI on the CIHR's expert working group.
I would like to address a third omission from the budget.
Some 2.7 million Canadians are affected by rare disorders such as cystic fibrosis, sickle cell disease and thalassemia. Most rare disorders are difficult to diagnose and are chronic, degenerative, progressive and life-threatening.
Families who face rare disorders lack access to scientific knowledge of their disease and to quality health care. They face difficulties and inequities in accessing treatment and care.
Canada is one of the only developed countries without a policy for rare disorders. As a result, Canadian patients are frequently excluded from many clinical trials and often have delayed access to treatment. Moreover, Canadian patients cannot always access drugs available to patients elsewhere. Only a fraction of the drugs approved in Europe and the U.S. are brought to Canada. Going forward, let us all commit to working together to develop a national policy for rare disorders.
I wish there were more time. I wish there were time to address the cuts that have decimated Environment Canada, particularly its adaptation group. Eight were fired in June, and twelve of 17 have received workforce adjustment letters. Many of these scientists share part of the 2007 Nobel Peace Prize for climate change.
Adaptation science is the bridge between climate predictions and practical applications. Why, then, would the minister cut climate impact and adaptation scientists? Does he really think an investment of $149 million will truly counter the problem? When will the Minister of the Environment restore activities in the Environment Canada adaptation group so that the economic well-being, health and safety of Canadians will be protected?